Lumibird Establishes Presence in Southeast Asia by Acquiring Its Malaysian Distributor
Lumibird, the European leader in laser technologies, has announced the acquisition of its long-standing distribution partner BIZ MEDIC SDN BHD, based in Kuala Lumpur, Malaysia. This move marks the creation of Lumibird Medical Southeast Asia, a new hub aimed at centralizing the group's activities in the region.
Lumibird Medical has finalized an agreement to acquire BIZ MEDIC SDN BHD, its distribution partner since 2004. This acquisition signifies a shift from a distribution model to a direct subsidiary approach, embedding the group in a strategy of strengthened presence in the Asia Pacific region. The establishment of Lumibird Medical Southeast Asia will position this area as the main growth driver for the group in a high-potential ophthalmological market. Southeast Asia is characterized by a strong clinical demand, notably high rates of visual disorders such as myopia, glaucoma, and retinal diseases, as well as a rapid increase in health infrastructure investments.
Operational Restructuring and Brand Presence
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The creation of the new hub will be accompanied by the simultaneous closure of the commercial office in Thailand and the subsidiary in India, thereby streamlining the group's regional operations. The new entity will organize the distribution of products from Quantel Medical, Optotek Medical, and Ellex, ensuring a unified brand presence tailored to the regulatory and clinical requirements of Southeast Asia. The completion of the operation is expected in the coming months, subject to obtaining certain local regulatory approvals. Lumibird Medical will continue to explore the potential sale of its medical division, the outcome of which remains uncertain.
SectorSanté · Défense · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 49.7M€
Guidance from the release
Le Groupe confirme ses objectifs pour 2026.
Chiffre d'affaires en hausse, croissance attendue pour 2026.
Risks mentioned
Perturbations logistiques pouvant affecter les livraisons.
Pression géopolitique impactant la chaîne d'approvisionnement.
Opportunities identified
Lancement de nouveaux produits attendu à partir de l'été.
Accélération prévue des activités Défense/Spatial.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
